Publication | Open Access

Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry

Rheumatoid DisorderRheumatologyEpidemiologyMedicineRheumatic DiseasesTherapeutic ControversyInflammatory Rheumatic DiseasePharmacotherapyRheumatoid Arthritis PatientsHead-to-head ComparisonSclerodermaPsoriatic ArthritisJapanese Ra PatientsRheumatoid Arthritis